UTMD
Utah Medical Products Inc
Utah Medical Products Inc Profile
About
Info & Links
CEO
Kevin L. Cornwell
Headquarters
Midvale, UT 84047, UNITED STATES
Industry
Sector
Website
Auditor
Haynie & Company
Share holders
--
Employees
152
Utah Medical Products Inc Statistics
Valuation Measures
Market Capitalization2
237.10M
Enterprise Value
149.57M
Enterprise Value/EBITDA(ttm)
11.75
Price to Earnings Ratio(ttm)
21.55
Price to Sales(ttm)
6.23
Price to Book(mrq)
1.84
Price to Cash(ytd)
15.84
Profitability
Gross Margin(ttm)
57.91%
Operating Margin(ttm)
29.04%
Profit Margin(ttm)
29.13%
Return on Equity(ttm)
8.74%
Return on Invested Capital(ttm)
8.74%
Return on Assets(ttm)
8.50%
Income Statement
Revenue(ttm)
36.11M
Revenue Per Share(ttm)
11.34
Gross Profit(ttm)
20.91M
EBITDA(ttm)3
12.73M
Net Income Available to Common(ttm)
10.49M
Diluted EPS(ttm)
3.28
Share Statistics
Beta (5Y Monthly)
0.35
52-Week Change
19.17%
S&P 500 52-Week Change
17.62%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
3.18M
Dividend Yield
1.75%
Float4
2.93M
% Held by Insiders
8.00%
% Held by Institutions
69.60%
Balance Sheet
Total Cash(mrq)
87.53M
Total Cash Per Share(mrq)
27.49
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
48.62%
Quick Ratio(mrq)
44.27%
Book Value Per Share(mrq)
38.34
Cash Flow
Operating Cash Flow Per Share(ytd)
1.41
Free Cash Flow(ytd)
4.23M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.